Translating cancer immunology into novel therapies against aggressive brain tumors.
Strickland Brain Tumor Immunology Lab
Medical University of South Carolina
Our Research Focus
Tumor Microenvironment
Investigating immunosuppressive properties of the glioblastoma microenvironment to identify actionable therapeutic targets.
Epigenetics & Glioblastoma
Exploring differential epigenetic expression patterns that drive malignant transformation in meningioma.
Targeted Immunotherapies
Engineering precise immunotherapy treatments for aggressive brain tumors not amenable to surgical intervention.
Techniques We Use
150+
Peer-Reviewed Publications
5
Active Research Programs
4
Lab Members
3
Institutional Partners
Latest Publication
Ventricular entry and postoperative leptomeningeal metastasis after resection of supratentorial high-grade glioma.
Abi Faraj C, McCutcheon IE, Strickland BA, et al.
J Neurosurg. 2026 Feb 13:1-15.
Ventricular entry (VE) during resection can maximize high-grade glioma (HGG) resection, but it remains unclear whether tumor contiguity to the ventricles or VE increases the risk of leptomeningeal metastasis (LM) and/or worsens overall survival (OS). To clarify the role of VE and tumor location in LM incidence and OS, the authors retrospectively reviewed the charts of patients who underwent their first resection of supratentorial HGG at The University of Texas MD Anderson Cancer Center between 1993 and 2021. The authors identified 884 patients: 390 (44%) had VE and 444 (50%) had ependymal contact (EC) tumors. On multivariate analysis, VE did not significantly predict LM or OS. However, EC significantly increased LM risk and worsened OS. Tumors with EC predict higher LM risk and shorter OS, while VE during resection does not increase LM risk or worsen OS. Surgeons can use VE to maximize resection of supratentorial HGGs without increasing the risk of subsequent LM.
Lab News
February 12, 2026
New publication on ventricular entry and leptomeningeal metastasis
Multi-institutional study on postoperative outcomes after resection of supratentorial high-grade glioma published in the Journal of Neurosurgery.
Read moreJanuary 14, 2026
Focused ultrasound review published in Brain Stimulation
Bell, Walton, et al. publish comprehensive review on engineering focused ultrasound approaches for glioblastoma therapy.
Read moreOctober 31, 2025
Lab presents at Society for Neuro-Oncology Annual Meeting
Multiple poster presentations showcasing our work on glioblastoma immunotherapy and meningioma epigenetics.
Who We Are

Principal Investigator
Ben Allen Strickland, MD
Assistant Professor, Department of Neurosurgery
Medical University of South Carolina
Hollings Cancer Center
Dr. Ben Allen Strickland's major area of clinical interest is brain, skull base, and pituitary surgery. His practice incorporates a variety of endoscopic and minimally invasive open neurosurgical techniques as well as stereotactic radiosurgery.
Interested in our work?
We are actively recruiting motivated researchers to join our team at MUSC.